PG vs RYTM · P/E 25, rev $84.28B vs rev $130.1M
Procter & Gamble Company (PG) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
PG currently screens at market cap $373.53B and trailing P/E 25.3. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the PG and RYTM stock pages for the full models.
Not investment advice.